Veranex, a provider of the first purpose-built, global service platform for the medtech industry, completed the acquisition of T3 Labs, a preclinical laboratory. Financial terms were not disclosed. "The addition of T3 Labs to the Veranex family allows us to further realize our mission of unifying the entire medtech development process, from concept to commercialization. The growth of the preclinical market, increasing regulatory requirements, and the need for efficient collaboration between clients and their product development partners make T3 Labs a strategic fit for Veranex and an incredible asset for our clients," Pat Donnelly, Veranex CEO.